DK1708722T3 - Ny interstitiel terapi til øjeblikkelig symptomlindring og kronisk terapived interstitiel cystit - Google Patents

Ny interstitiel terapi til øjeblikkelig symptomlindring og kronisk terapived interstitiel cystit

Info

Publication number
DK1708722T3
DK1708722T3 DK05712839.9T DK05712839T DK1708722T3 DK 1708722 T3 DK1708722 T3 DK 1708722T3 DK 05712839 T DK05712839 T DK 05712839T DK 1708722 T3 DK1708722 T3 DK 1708722T3
Authority
DK
Denmark
Prior art keywords
interstitial
therapyced
cystit
chronic
new
Prior art date
Application number
DK05712839.9T
Other languages
English (en)
Inventor
Lowell C Parsons
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34826198&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1708722(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of DK1708722T3 publication Critical patent/DK1708722T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
DK05712839.9T 2004-01-28 2005-01-27 Ny interstitiel terapi til øjeblikkelig symptomlindring og kronisk terapived interstitiel cystit DK1708722T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54018604P 2004-01-28 2004-01-28
PCT/US2005/003542 WO2005072751A1 (en) 2004-01-28 2005-01-27 Novel interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis

Publications (1)

Publication Number Publication Date
DK1708722T3 true DK1708722T3 (da) 2014-08-25

Family

ID=34826198

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05712839.9T DK1708722T3 (da) 2004-01-28 2005-01-27 Ny interstitiel terapi til øjeblikkelig symptomlindring og kronisk terapived interstitiel cystit

Country Status (10)

Country Link
US (4) US7414039B2 (da)
EP (2) EP1708722B1 (da)
AU (1) AU2005209322B2 (da)
CA (1) CA2554489A1 (da)
DK (1) DK1708722T3 (da)
ES (1) ES2493626T3 (da)
PL (1) PL1708722T3 (da)
PT (1) PT1708722E (da)
SI (1) SI1708722T1 (da)
WO (1) WO2005072751A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003094937A1 (en) 2002-05-09 2003-11-20 Medigenes A pharmaceutical composition for treatment of wounds containing blood plasma or serum
ES2748058T3 (es) * 2005-01-14 2020-03-12 Urigen Inc Kits y composiciones para tratar trastornos del tracto urinario inferior
CA2618349C (en) 2005-08-11 2016-05-31 Massachusetts Institute Of Technology Intravesical drug delivery device and method
US20070172508A1 (en) * 2006-01-26 2007-07-26 Paul Zupkas Transluminal drug delivery methods and devices
DE102006060953A1 (de) * 2006-12-12 2008-08-07 Farco-Pharma Gmbh Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes
EP2607477B1 (en) * 2007-05-03 2020-09-23 The Brigham and Women's Hospital, Inc. Multipotent stem cells and uses thereof
US8574567B2 (en) * 2007-05-03 2013-11-05 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
US8828452B2 (en) * 2007-05-22 2014-09-09 Glenn Abrahmsohn Method for pain control
BRPI0820800B8 (pt) * 2007-12-11 2021-06-22 Massachusetts Inst Technology dispositivo médico implantável para liberação controlada de droga
CN102176931B (zh) 2008-08-09 2015-03-04 麻省理工学院 治疗男性泌尿生殖组织和外周组织的可植入药物递送设备和方法
FR2938187B1 (fr) † 2008-11-07 2012-08-17 Anteis Sa Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
WO2010085589A2 (en) 2009-01-22 2010-07-29 G&H Brands Llc Desensitizing drug product
ES2401007T3 (es) 2009-06-26 2013-04-16 Taris Biomedical, Inc. Dispositivos de administración de fármaco implantables y procedimientos de fabricación de los mismos
WO2011019963A2 (en) * 2009-08-13 2011-02-17 Singularis, Inc. Prg4 treatment for interstitial cystitis
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
NZ599527A (en) 2009-11-09 2014-04-30 Spotlight Technology Partners Llc Fragmented hydrogels
WO2011057131A1 (en) 2009-11-09 2011-05-12 Spotlight Technology Partners Llc Polysaccharide based hydrogels
AU2011213175A1 (en) * 2010-02-04 2014-02-20 Michael M. Goldberg Use of oral heparin preparations to treat urinary tract diseases and conditions
DK2600848T3 (da) 2010-08-05 2019-06-24 Taris Biomedical Llc Implanterbare lægemiddelafgivelsesindretninger til urogenitale positioner
WO2012094515A1 (en) * 2011-01-06 2012-07-12 Parsons C Lowell Method for manufacturing composition comprising local anesthetic, heparinoid, and buffer
CA2823783C (en) 2011-01-10 2023-03-21 Taris Biomedical, Inc. Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
CN103379902B (zh) 2011-02-04 2015-11-25 塔里斯生物医药公司 用于低溶解度药物的控制释放的可植入装置
US9849086B2 (en) * 2012-03-19 2017-12-26 Nanologix Research, Inc. Method and composition for treating cystitis
EP2948154A4 (en) * 2013-01-28 2016-09-14 Urigen Pharmaceuticals Inc STABLE COMPOSITIONS COMPRISING A HEPARINOID, A LOCAL ANESTHETIC AND A BUFFER
RU2666684C2 (ru) 2013-03-15 2018-09-11 ТАРИС Биомедикал ЛЛК Устройство для доставки лекарственных средств с проницаемым для лекарственного средства компонентом и способ доставки лекарственных средств
CN113413393A (zh) 2013-08-19 2021-09-21 塔里斯生物医药公司 多单元药物递送装置和方法
KR20170003527A (ko) * 2014-02-24 2017-01-09 유리젠 파마슈티컬스, 인코포레이티드 경구 투여용 펜토산 폴리설페이트 염의 조성물
RU2586285C1 (ru) * 2015-03-24 2016-06-10 Общество с ограниченной ответственностью "ФармСинергия" Водная композиция для инстилляций в мочевой пузырь
WO2016172704A1 (en) 2015-04-23 2016-10-27 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods
US10004824B2 (en) 2015-05-11 2018-06-26 Laboratoires Vivacy Compositions comprising at least one polyol and at least one anesthetic
CN111787915A (zh) * 2017-04-12 2020-10-16 尤里根制药股份有限公司 注射器中包含局部麻醉剂、缓冲剂和糖胺聚糖的稳定性提高的制品
RU2648443C1 (ru) * 2017-05-10 2018-03-26 Федеральное государственное бюджетное учреждение "Новосибирский научно-исследовательский институт туберкулеза" Министерства здравоохранения Российской Федерации (ФГБУ "ННИИТ" Минздрава России) Способ профилактики обострения посткоитального цистита
CN113710254B (zh) * 2019-04-26 2024-03-12 泰宗生物科技股份有限公司 用于预防反复性泌尿道感染的药学组合物
EP3998932A4 (en) * 2019-07-18 2023-08-16 C. Lowell Parsons ALKALINIZATION OF THE URINARY BLADDER WALL BEFORE TREATMENT WITH INTRAVESICAL HEPARIN AND ALKALIZED LIDOCAINE TO ENHANCE SYMPTOMS RELIEF OF PAIN BLADDER
WO2021009525A1 (en) * 2019-07-18 2021-01-21 Lovasz Sandor Medicinal and/or pharmaceutical compositions for intravesical instillation, preparation and use thereof
HUP2000144A1 (hu) * 2020-04-29 2022-04-28 Lovasz Sandor Dr Vizelet lúgosító gyógyászati és/vagy gyógyszerkészítmény interstitialis cystitis / hólyagfájdalom szindróma (IC/BPS)orális kezelésére és formulálása

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268518A (en) * 1979-05-19 1981-05-19 Fisons Limited Method of treating cystitis
US4460360A (en) 1982-08-30 1984-07-17 Finegold Aaron N Urethral anesthetic devices
US4879282A (en) 1987-03-17 1989-11-07 Saliba Jr Michael J Medical application for heparin and related molecules
US5037810A (en) 1987-03-17 1991-08-06 Saliba Jr Michael J Medical application for heparin and related molecules
US5196405A (en) 1987-07-08 1993-03-23 Norman H. Oskman Compositions and methods of treating hemorrhoids and wounds
US5104856A (en) * 1990-11-09 1992-04-14 Uab Research Foundation Heparan sulfate biosynthesis primers
US5137528A (en) 1990-11-26 1992-08-11 Crose Virginia W Ampoule for administering a liquid local anaesthetic
AU2441592A (en) * 1991-08-08 1993-03-02 Leigh D. Segel Fluorocarbon blood substitute
GB9310095D0 (en) 1993-05-17 1993-06-30 Zeneca Ltd Therapeutic compounds
US5749845A (en) * 1995-01-25 1998-05-12 Iotek, Inc. Delivering an agent to an organ
ZA962455B (en) * 1995-03-31 1996-10-02 B Eugene Guthery Fast acting and persistent topical antiseptic
US5972326A (en) * 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
JP2000505090A (ja) 1996-07-11 2000-04-25 ファーマーク、ニーダーランド、ベスローテン、フェンノートシャップ インドール選択的セロトニンアゴニストを含む包接錯体
US5879282A (en) * 1997-01-21 1999-03-09 Cordis A Johnson And Johnson Company Catheter having an expandable radioactive source
US6159944A (en) 1998-02-27 2000-12-12 Synchroneuron, Llc Method for treating painful conditions of the anal region and compositions therefor
US6083933A (en) 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
RU2147876C1 (ru) * 1999-07-08 2000-04-27 Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" Фармацевтическая композиция для обезболивания в офтальмологии
US20040047910A1 (en) 2000-07-07 2004-03-11 Christian Beckett Suppository and composition comprising at least one polyethylene glycol
US6648863B2 (en) 2000-09-20 2003-11-18 Scimed Life Systems, Inc. Apparatus and methods for treating the urinary bladder
BRPI0115531B1 (pt) 2000-11-22 2015-10-13 Rxkinetix Inc composição terapêutica útil para o tratamento de mucosite em um local de mucosa como efeito colateral de terapia de câncer
US20040037896A1 (en) * 2000-12-08 2004-02-26 Ernst Pieter Theo Therapeutic treatment
US20040142968A1 (en) 2003-01-17 2004-07-22 Donald Price Method and kit for treating lower bowel pain
EP1589959A2 (en) 2003-01-30 2005-11-02 Dynogen Pharmaceuticals Inc. Methods of treating lower urinary tract disorders using sodium channel modulators
US20040161476A1 (en) * 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
US20040248979A1 (en) 2003-06-03 2004-12-09 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
ES2748058T3 (es) * 2005-01-14 2020-03-12 Urigen Inc Kits y composiciones para tratar trastornos del tracto urinario inferior

Also Published As

Publication number Publication date
AU2005209322A1 (en) 2005-08-11
PL1708722T3 (pl) 2014-10-31
CA2554489A1 (en) 2005-08-11
ES2493626T3 (es) 2014-09-12
EP2813231A1 (en) 2014-12-17
AU2005209322B2 (en) 2011-05-19
US7414039B2 (en) 2008-08-19
EP1708722B1 (en) 2014-05-21
US20080300219A1 (en) 2008-12-04
PT1708722E (pt) 2014-09-12
WO2005072751A1 (en) 2005-08-11
SI1708722T1 (sl) 2014-10-30
US9486474B2 (en) 2016-11-08
EP1708722A1 (en) 2006-10-11
EP1708722A4 (en) 2009-04-01
US20170007638A1 (en) 2017-01-12
US20050234013A1 (en) 2005-10-20
US20190321391A1 (en) 2019-10-24

Similar Documents

Publication Publication Date Title
DK1708722T3 (da) Ny interstitiel terapi til øjeblikkelig symptomlindring og kronisk terapived interstitiel cystit
IS7977A (is) Samsetningar og aðferð til samsettra meðferðar
DE602005001973D1 (de) Matratze mit Fersendruckentlastungsteil
DK1799171T3 (da) Ambulanceseng og hydraulisk elevationsmekanisme dertil
IS8204A (is) Tæki og aðferð til að hluta niður
DK1753406T4 (da) Overtrukket tabletformulering og fremgangsmåde
DK1928457T3 (da) Quinoliner og deres terapeutiske anvendelse
NO20070251A (no) Brønnbehandling
DK1715893T3 (da) Direkte kompressionsformulering og fremgangsmåde
DK1765859T3 (da) Annexiner, derivater deraf og annexin-cys varianter samt terapeutiske og diagnostiske anvendelser deraf
DK1933810T3 (da) Intravesikal lægemiddelafgivelsesindretning og fremgangsmåde
NO20070297A (no) Brønnbehandling
DK1969846T3 (da) Systemer og fremgangsmåder til at administrere indhold
DK2878297T3 (da) Lægemidler til behandling og forebyggelse af fibrotiske sygdomme
DK1890588T3 (da) Ambulant lægemiddelindretning og fremgangsmåde til kommunikation mellem lægemiddelindretninger
EE05505B1 (et) Personaalne teraapiasektsioon
DK1919514T3 (da) Polynucleotider kodende for isoprenoid-modificerende enzymer og fremgangsmåder til anvendelse deraf
DK1937276T3 (da) Forbedret testosterongel og fremgangsmåde til anvendelse deraf
DK1708994T3 (da) Aryloxyalkylcarbamatderivater, fremstilling og anvendelse herfra inden for terapi
DK1797269T3 (da) Multifunktionelt og bærbart sikkerhedssystem
DK1937332T3 (da) Infusionsapparat og aktuator hertil
DK1773829T3 (da) Aminotropanderivater, fremstilling og terapeutiske anvendelser heraf
DE602005019913D1 (de) Therapeutische pyrazoloä3,4-büpyridine und -indazole
IS7572A (is) Aðferð og efni til lækninga
EP1778228A4 (en) THERAPEUTIC CONNECTION AND TREATMENTS